124 related articles for article (PubMed ID: 25803094)
1. Minor contribution of biliary excretion in lithium elimination in rats.
Uwai Y; Kawasaki T; Nabekura T
Drug Metab Pers Ther; 2015 Mar; 30(1):65-7. PubMed ID: 25803094
[TBL] [Abstract][Full Text] [Related]
2. Effect of renal ischemia on urinary excretion of lithium in rats.
Uwai Y; Suzuki T; Kondo R; Kawasaki T; Nabekura T
Biopharm Drug Dispos; 2018 Nov; 39(9):448-451. PubMed ID: 30393876
[TBL] [Abstract][Full Text] [Related]
3. Enantioselective Effect of Flurbiprofen on Lithium Disposition in Rats.
Uwai Y; Matsumoto M; Kawasaki T; Nabekura T
Pharmacology; 2017; 99(5-6):236-239. PubMed ID: 28147361
[TBL] [Abstract][Full Text] [Related]
4. Sodium-phosphate cotransporter mediates reabsorption of lithium in rat kidney.
Uwai Y; Arima R; Takatsu C; Furuta R; Kawasaki T; Nabekura T
Pharmacol Res; 2014 Sep; 87():94-8. PubMed ID: 24997387
[TBL] [Abstract][Full Text] [Related]
5. Effect of Experimental Fanconi Syndrome on Tubular Reabsorption of Lithium in Rats.
Uwai Y; Nabekura T
Pharmacology; 2021; 106(7-8):446-450. PubMed ID: 33979799
[TBL] [Abstract][Full Text] [Related]
6. Lithium administered to pregnant, lactating and neonatal rats: entry into developing brain.
Chiou SY; Kysenius K; Huang Y; Habgood MD; Koehn LM; Qiu F; Crouch PJ; Varshney S; Ganio K; Dziegielewska KM; Saunders NR
Fluids Barriers CNS; 2021 Dec; 18(1):57. PubMed ID: 34876168
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and ADME Characterization of Intravenous and Oral [
Zamek-Gliszczynski MJ; Kenworthy D; Bershas DA; Sanghvi M; Pereira AI; Mudunuru J; Crossman L; Pirhalla JL; Thorpe KM; Dennison JMTJ; McLaughlin MM; Allinder M; Swift B; O'Connor-Semmes RL; Young GC
Drug Metab Dispos; 2021 Dec; 49(12):1109-1117. PubMed ID: 34625435
[TBL] [Abstract][Full Text] [Related]
8. Uptake of lithium into rat brain after acute and chronic administration.
Hillert M; Zimmermann M; Klein J
Neurosci Lett; 2012 Jul; 521(1):62-6. PubMed ID: 22659074
[TBL] [Abstract][Full Text] [Related]
9. Lithium evokes a more pronounced natriuresis when administered orally than when given intravenously to salt-depleted rats.
Mu J; Johansson M; Hansson GC; Lundgren O
Pflugers Arch; 1999 Jul; 438(2):159-64. PubMed ID: 10370102
[TBL] [Abstract][Full Text] [Related]
10. Lithium decreases VEGF mRNA expression in leukocytes of healthy subjects and patients with bipolar disorder.
Kikuchi K; Iga J; Tayoshi S; Nakataki M; Watanabe S; Numata S; Ohmori T
Hum Psychopharmacol; 2011; 26(4-5):358-63. PubMed ID: 21721043
[TBL] [Abstract][Full Text] [Related]
11. Effects of lithium on the pharmacokinetics of valproate in rats.
Yoshioka H; Ida S; Yokota M; Nishimoto A; Shibata S; Sugawara A; Takiguchi Y
J Pharm Pharmacol; 2000 Mar; 52(3):297-301. PubMed ID: 10757417
[TBL] [Abstract][Full Text] [Related]
12. Effect of carrageenan-induced acute peripheral inflammation on the electrolyte disposition to cerebrospinal fluid in rats.
Kono K; Okada A; Ishikawa A; Aiba T
Biol Pharm Bull; 2013; 36(11):1829-34. PubMed ID: 24189427
[TBL] [Abstract][Full Text] [Related]
13. Decreased lithium disposition to cerebrospinal fluid in rats with glycerol-induced acute renal failure.
Sakae R; Ishikawa A; Niso T; Komori Y; Aiba T; Kawasaki H; Kurosaki Y
Pharm Res; 2008 Oct; 25(10):2243-9. PubMed ID: 18581208
[TBL] [Abstract][Full Text] [Related]
14. Chronic lithium treatment protects the rat kidney against ischemia/reperfusion injury: the role of nitric oxide and cyclooxygenase pathways.
Talab SS; Emami H; Elmi A; Nezami BG; Assa S; Deroee AF; Daneshmand A; Tavangar SM; Dehpour AR
Eur J Pharmacol; 2010 Nov; 647(1-3):171-7. PubMed ID: 20826134
[TBL] [Abstract][Full Text] [Related]
15. Excretion of lithium by kidney, bile and faeces in rats of different ages.
Kersten L; Barth A
Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):4-13. PubMed ID: 7165421
[TBL] [Abstract][Full Text] [Related]
16. Influence of lithium on biliary electrolyte and bile acid excretion in young and adult rats.
Kersten L; Barth A
Acta Physiol Hung; 1985; 65(2):129-35. PubMed ID: 3984756
[TBL] [Abstract][Full Text] [Related]
17. Effect of Chronic Kidney Disease on Hepatic Clearance of Drugs in Rats.
Tokunaga A; Miyamoto H; Fumoto S; Nishida K
Biol Pharm Bull; 2020; 43(9):1324-1330. PubMed ID: 32879206
[TBL] [Abstract][Full Text] [Related]
18. Quantitative evaluation of biliary elimination of gadoxetate, a magnetic resonance imaging contrast agent, via geometrical isomer-specific transporting system in rats.
Ogawa J; Yokota A; Araki T; Aomori T; Nakamura T; Yamamoto K; Koshiishi I
Biopharm Drug Dispos; 2014 Sep; 35(6):362-71. PubMed ID: 24947335
[TBL] [Abstract][Full Text] [Related]
19. Potent Inhibition of Biphasic Tubular Reabsorption of Lithium by Acetazolamide and Foscarnet in Rats.
Uwai Y; Kondo R; Suzuki T; Kawasaki T; Nabekura T
Physiol Res; 2020 Aug; 69(4):645-651. PubMed ID: 32584131
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
